Amedeo's Top 20

Amedeo Smart

Independent Medical Education


03 August 2020

Multidisciplinary Journal Club

  1. Alping P, Askling J, Burman J, Fink K, et al.
    Cancer Risk for Fingolimod, Natalizumab, and Rituximab in MS Patients.
    Ann Neurol 2020.

  1. Schepers NJ, Hallensleben NDL, Besselink MG, Anten MGF, et al.
    Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial.
    Lancet 2020;396:167-176.

  2. Kaptchuk TJ, Hemond CC, Miller FG.
    Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice.
    BMJ 2020;370:m1668.

  3. Baumeister SE, Karch A, Bahls M, Teumer A, et al.
    Physical activity and risk of Alzheimer's disease: a two-sample Mendelian randomization study.
    Neurology 2020.

  4. Wasmuth HH, Faerden AE, Myklebust TA, Pfeffer F, et al.
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg 2020;107:121-130.

  1. Ramos CA, Grover NS, Beaven AW, Lulla PD, et al.
    Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
    J Clin Oncol 2020.

  2. Simon J, Chaix M, Billa O, Kamga AM, et al.
    Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study.
    Br J Cancer 2020.

  3. Harvey PD.
    An Array of Studies Addressing Cognition and Cognitively Defined Neuropsychiatric Conditions: Many More Connections Than You Might Think.
    Am J Psychiatry 2020;177:491-496.

  4. Lewis KL, Chin CK, Manos K, Casey J, et al.
    Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience.
    Br J Haematol 2020.

  5. Pencina M, Pencina K, Lloyd-Jones D, Catapano AL, et al.
    The Expected 30-year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering.
    Circulation 2020.

  1. Hauser SL, Kappos L, Arnold DL, Bar-Or A, et al.
    Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
    Neurology 2020.

  2. Zala A, Berhane T, Juhlin CC, Calissendorff J, et al.
    Riedel's Thyroiditis.
    J Clin Endocrinol Metab 2020.

  3. Busch LM, Kadri SS.
    Antimicrobial Treatment Duration in Sepsis and Serious Infections.
    J Infect Dis 2020;222:S142-S155.

  4. Soverini S, Bavaro L, De Benedittis C, Martelli M, et al.
    Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
    Blood 2020;135:534-541.

  5. Stephens AR, Presson AP, McFarland MM, Zhang C, et al.
    Volar Locked Plating Versus Closed Reduction and Casting for Acute, Displaced Distal Radial Fractures in the Elderly: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Bone Joint Surg Am 2020;102:1280-1288.

  1. Gray JP, Muller VI, Eickhoff SB, Fox PT, et al.
    Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.
    Am J Psychiatry 2020;177:422-434.

  2. Naghshi S, Sadeghi O, Willett WC, Esmaillzadeh A, et al.
    Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies.
    BMJ 2020;370:m2412.

  3. Lewiecki EM, Binkley N, Clark P, Kim S, et al.
    Core principles for fracture prevention: North American Consensus from the National Osteoporosis Foundation, Osteoporosis Canada, and Academia Nacional de Medicina de Mexico.
    Osteoporos Int 2020.

  4. Tchivileva IE, Hadgraft H, Lim PF, Di Giosia M, et al.
    Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial.
    Pain 2020;161:1755-1767.

  5. Corr BR, Moroney M, Sheeder J, Eckhardt SG, et al.
    Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
    Cancer 2020.


more..


Privacy Policy